About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
Company Profile Why Invest? Events Calendar Management Views Financial Reporting Shareholder Information
Q4
Down Arrow
Q3
Q2
Q1
Contact IR
 
TSX:  $15.46 (0.00)
NYSE:  $11.81 (0.00)
  15 minute delay
Uranium Price
Print Page
Print Page

Cash Statement

Consolidated Statements of Cash Flows
(Unaudited)
($Cdn Thousands)

Three Months Ended   Year Ended
Dec 31/07    Dec 31/06    Dec 31/07    Dec 31/06
 
Operating activities  
Net earnings $61,498  $40,340  $416,112  $375,715 
  Items not requiring (providing) cash:  
    Depreciation, depletion and reclamation 56,672  58,642  225,539  199,665 
  Provision for future taxes [note 11] (25,950) (49,330) (134,129) (184,639)
  Deferred charges (gains) 13,505  (3,793) (18,441) (43,449)
  Unrealized losses (gains) on derivatives 1,487  9,702  (50,032) 10,400 
  Stock-based compensation [note 13] 5,567  2,995  13,770  17,549 
  Stock option plan amendment [note 13] -   -   94,175  -  
  Loss (gain) on sale of assets [note 9] (927) 458  (4,028) (51,826)
  Equity in loss of associated companies [note 10] 973  744  6,439  5,320 
  Restructuring of gold business [note 16] 8,000  -   113,000  -  
  Cigar Lake remediation -   15,356  -   15,356 
  Minority interest 7,395  3,008  20,352  38,554 
  Other operating items [note 15] (71,176) (64,810) 117,969  35,375 
Cash provided by operations 57,044  13,312  800,726  418,020 
 
Investing activities  
  Acquisition of net business assets, net of cash acquired -   -   -   (83,856)
  Additions to property, plant and equipment (135,461) (148,576) (494,473) (459,559)
  Increase in long-term receivables, investments and other 2,322  (2,562) (38,167) (29,687)
  Proceeds on sale of property, plant and equipment 926  46  5,824  46,404 
Cash used in investing (132,213) (151,092) (526,816) (526,698)
 
Financing activities  
  Shares repurchased [note 7] (205,356) -   (429,327) -  
  Decrease in debt (2,050) (1,700) (7,900) (156,700)
  Increase in debt 28,126  -   43,815  -  
  Issue of shares 215  1,882  23,289  27,058 
  Dividends (17,447) (14,084) (66,906) (52,660)
Cash used in financing (196,512) (13,902) (437,029) (182,302)
  Decrease in cash during the period (271,681) (151,682) (163,119) (290,980)
  Exchange rate changes on foreign currency cash balances 296  12,642  (39,038) 1,876 
  Cash and cash equivalents at beginning of period 403,317  473,129  334,089  623,193 
Cash and cash equivalents at end of period* $131,932  $334,089  $131,932  $334,089 
 
Supplemental cash flow disclosure  
  Interest paid $11,287  $11,334  $47,691  $53,551 
  Income taxes paid $21,377  $22,659  $154,748  $115,352 
 
*As at December 31, 2007, our cash and cash equivalents balance consisted of $89,438 in cash and $42,494 in cash equivalents (primarily treasury bills). As at December 31, 2006 - $73,159 in cash and $260,930 in cash equivalents (primarily commercial paper).
 
See accompanying notes to consolidated financial statements